Life-threatening asthma attack during prolonged fingolimod treatment: case report

BACKGROUND: Fingolimod (FTY) mediates bronchoconstriction by interacting with sphingosine-1-phosphate receptors. The majority of the reported adverse respiratory events occur during the first weeks of treatment. CASE PRESENTATION: A 49-year-old woman developed a life-threatening asthma attack after...

Descripción completa

Detalles Bibliográficos
Autores principales: Zecca, Chiara, Caporro, Matteo, Györik, Sandor, Gobbi, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105229/
https://www.ncbi.nlm.nih.gov/pubmed/25053881
http://dx.doi.org/10.2147/PPA.S65708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105229/
https://www.ncbi.nlm.nih.gov/pubmed/25053881
http://dx.doi.org/10.2147/PPA.S65708

Ejemplares similares